Table 5.
FQ | AZ/ST | FQ | AZ/ST | Crude OR | Adjusted OR | |
---|---|---|---|---|---|---|
(N, col. %) | (N, col. %) | (95% CI) | (95% CI) | (95% CI) | (95% CI) | |
N | 119,653 | 119,653 | ||||
> = 2 SOC AEs + Disability |
264 | 243 | 0.002 | 0.002 | 1.09 | 1.09 |
0.22% | 0.20% | (0.002–0.002) | (0.002–0.002) | (0.92–1.30) | (0.91–1.30) | |
p = 0.35 | ||||||
calibrated p = 0.84 | ||||||
Sensitivity Analyses | ||||||
> = 2 SOC AEs + Disability |
205 | 182 | 0.002 | 0.002 | 1.13 | 1.13 |
0.17% | 0.15% | (0.001–0.002) | (0.001–0.002) | (0.92–1.37) | (0.92–1.38) | |
p = 0.24 | ||||||
calibrated p = 0.89 |
Abbreviations: AZ Azithromycin, FQ Fluoroquinolone, ST Sulfamethoxazole / Trimethoprim